RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
Romei, C., Cosci, B., Renzini, G., Bottici, V., Molinaro, E., Agate, L., Passannanti, P., Viola, D., Biagini, A., Basolo, F., Ugolini, C., Materazzi, G., Pinchera, A., Vitti, P., Elisei, R.
Published in Clinical endocrinology (Oxford) (01.02.2011)
Published in Clinical endocrinology (Oxford) (01.02.2011)
Get full text
Journal Article
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC): Clinical benefits of RET genetic screening
Romei, C., Cosci, B., Renzini, G., Bottici, V., Molinaro, E., Agate, L., Passannanti, P., Viola, D., Biagini, A., Basolo, F., Ugolini, C., Materazzi, G., Pinchera, A., Vitti, P., Elisei, R.
Published in Clinical endocrinology (Oxford) (01.02.2011)
Published in Clinical endocrinology (Oxford) (01.02.2011)
Get full text
Journal Article